With TheraTears, Prestige Consumer Sees Way To Boost Guidance Despite COVID, Cost Uncertainties

 
• By Malcolm Spicer

More than 17% growth in consumer health product sales in latest quarter on top of adding TheraTears brands to its lineup at start of current quarter outweighs potential headwinds from costs and changes in consumer spending, Prestige Consumer executives say.

Prestige Consumer Healthcare starts its FY2022 with higher returns in sales, net income and EPS driven by higher spending on advertising/marketing and on costs of goods sold.

More from International

More from Geography